vs
Nextdoor Holdings, Inc.（NXDR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Nextdoor Holdings, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的2.0倍（$69.5M vs $35.5M），Nextdoor Holdings, Inc.净利率更高（-5.8% vs -304.2%，领先298.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 6.5%），Nextdoor Holdings, Inc.自由现金流更多（$9.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 14.3%）
Nextdoor Holdings, Inc.是一家美国企业，主打面向社区的超本地社交网络服务。公司成立于2008年，总部位于加利福尼亚州旧金山，2011年10月在美国正式推出服务。截至2023年5月，业务已覆盖11个国家，2024年数据显示其平台会员数量达8800万。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NXDR vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.5M | $35.5M |
| 净利润 | $-4.0M | $-108.1M |
| 毛利率 | 84.9% | 59.8% |
| 营业利润率 | -10.7% | -304.8% |
| 净利率 | -5.8% | -304.2% |
| 营收同比 | 6.5% | 681.7% |
| 净利润同比 | 66.7% | 39.6% |
| 每股收益（稀释后） | $-0.01 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $69.5M | $35.5M | ||
| Q3 25 | $68.9M | $5.2M | ||
| Q2 25 | $65.1M | $19.2M | ||
| Q1 25 | $54.2M | $14.7M | ||
| Q4 24 | $65.2M | $4.5M | ||
| Q3 24 | $65.6M | $26.1M | ||
| Q2 24 | $63.3M | $14.4M | ||
| Q1 24 | $53.1M | $13.8M |
| Q4 25 | $-4.0M | $-108.1M | ||
| Q3 25 | $-12.9M | $-162.3M | ||
| Q2 25 | $-15.4M | $-171.9M | ||
| Q1 25 | $-22.0M | $-202.5M | ||
| Q4 24 | $-12.1M | $-178.9M | ||
| Q3 24 | $-14.9M | $-95.8M | ||
| Q2 24 | $-42.8M | $-97.5M | ||
| Q1 24 | $-28.3M | $-91.4M |
| Q4 25 | 84.9% | 59.8% | ||
| Q3 25 | 84.9% | -183.8% | ||
| Q2 25 | 83.6% | -4.9% | ||
| Q1 25 | 82.6% | -48.0% | ||
| Q4 24 | 84.0% | -181.4% | ||
| Q3 24 | 83.0% | 53.7% | ||
| Q2 24 | 83.8% | 36.2% | ||
| Q1 24 | 81.2% | 19.1% |
| Q4 25 | -10.7% | -304.8% | ||
| Q3 25 | -25.0% | -3327.6% | ||
| Q2 25 | -31.1% | -916.8% | ||
| Q1 25 | -49.9% | -1297.9% | ||
| Q4 24 | -26.2% | -4042.4% | ||
| Q3 24 | -31.7% | -377.1% | ||
| Q2 24 | -77.4% | -697.4% | ||
| Q1 24 | -65.4% | -698.4% |
| Q4 25 | -5.8% | -304.2% | ||
| Q3 25 | -18.7% | -3135.3% | ||
| Q2 25 | -23.6% | -894.2% | ||
| Q1 25 | -40.5% | -1373.3% | ||
| Q4 24 | -18.6% | -3935.5% | ||
| Q3 24 | -22.7% | -367.5% | ||
| Q2 24 | -67.6% | -676.6% | ||
| Q1 24 | -53.2% | -662.4% |
| Q4 25 | $-0.01 | $-0.17 | ||
| Q3 25 | $-0.03 | $-0.36 | ||
| Q2 25 | $-0.04 | $-0.41 | ||
| Q1 25 | $-0.06 | $-0.50 | ||
| Q4 24 | $-0.03 | $-0.56 | ||
| Q3 24 | $-0.04 | $-0.34 | ||
| Q2 24 | $-0.11 | $-0.40 | ||
| Q1 24 | $-0.07 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $431.3M | $1.1B |
| 总资产 | $486.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $63.3M | $743.3M | ||
| Q3 25 | $56.1M | $659.8M | ||
| Q2 25 | $62.0M | $525.1M | ||
| Q1 25 | $57.3M | $500.5M | ||
| Q4 24 | $45.5M | $594.4M | ||
| Q3 24 | $49.7M | $427.6M | ||
| Q2 24 | $53.0M | $474.3M | ||
| Q1 24 | $69.7M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $431.3M | $1.1B | ||
| Q3 25 | $429.7M | $1.0B | ||
| Q2 25 | $429.5M | $919.1M | ||
| Q1 25 | $436.1M | $933.9M | ||
| Q4 24 | $453.5M | $1.0B | ||
| Q3 24 | $456.0M | $524.6M | ||
| Q2 24 | $472.3M | $584.4M | ||
| Q1 24 | $541.4M | $401.2M |
| Q4 25 | $486.8M | $1.5B | ||
| Q3 25 | $488.9M | $1.4B | ||
| Q2 25 | $490.4M | $1.3B | ||
| Q1 25 | $495.0M | $1.3B | ||
| Q4 24 | $514.0M | $1.4B | ||
| Q3 24 | $517.7M | $726.5M | ||
| Q2 24 | $542.1M | $775.9M | ||
| Q1 24 | $633.1M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $9.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 13.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $9.5M | $-46.1M | ||
| Q3 25 | $-6.3M | $-117.4M | ||
| Q2 25 | $2.9M | $-76.4M | ||
| Q1 25 | $368.0K | $-132.0M | ||
| Q4 24 | $11.8M | $-115.4M | ||
| Q3 24 | $-13.0M | $-59.2M | ||
| Q2 24 | $-5.4M | $-82.2M | ||
| Q1 24 | $-13.6M | $-102.3M |
| Q4 25 | $9.4M | $-47.3M | ||
| Q3 25 | $-6.5M | $-117.6M | ||
| Q2 25 | $2.6M | $-79.6M | ||
| Q1 25 | $340.0K | $-133.8M | ||
| Q4 24 | $11.7M | $-116.7M | ||
| Q3 24 | $-13.2M | $-63.8M | ||
| Q2 24 | $-5.5M | $-83.4M | ||
| Q1 24 | $-13.6M | $-109.0M |
| Q4 25 | 13.5% | -133.1% | ||
| Q3 25 | -9.4% | -2272.5% | ||
| Q2 25 | 4.1% | -413.9% | ||
| Q1 25 | 0.6% | -907.4% | ||
| Q4 24 | 17.9% | -2567.7% | ||
| Q3 24 | -20.1% | -244.6% | ||
| Q2 24 | -8.6% | -578.5% | ||
| Q1 24 | -25.7% | -789.9% |
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.2% | 4.7% | ||
| Q2 25 | 0.5% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 0.3% | 17.5% | ||
| Q2 24 | 0.2% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NXDR
| US | $67.1M | 97% |
| Non Us | $2.3M | 3% |
RXRX
暂无分部数据
